REPAGLINIDE (REPAGLINIDE) — FDA Approval ANDA091517 (KENTON)
REPAGLINIDE (REPAGLINIDE) — FDA Approval ANDA091517 (KENTON) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: REPAGLINIDE; Active ingredients: REPAGLINIDE; Application number: ANDA091517.
| Brand name | REPAGLINIDE |
|---|---|
| Active ingredients | REPAGLINIDE |
| Application number | ANDA091517 |
| Sponsor | KENTON |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 3 |
| First approval date | 20150424 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →